{"entity":{"type":"insider","cik":"0001733375","url":"/insider/0001733375","json_url":"/insider/0001733375.json","name":"Anicetti Vincent R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":22,"first":"2019-07-17","last":"2021-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Anicetti Vincent R","source":"filing","n_filings":22,"first_seen":"2019-07-17","last_seen":"2021-03-09"}],"transactions":[{"id":4995960,"accession":"0001567619-21-005917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-005917","line_url":"/filing/0001567619-21-005917","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26649.0,"shares_display":"26,649","price_per_share":15.462667717362752,"price_display":"15.46","price_state":"stated","total_value":412064.632,"total_display":"412,064.63","total_whole":"412,065","shares_owned_after":59739.0,"shares_owned_after_display":"59,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider","n_lines":2},{"id":4638326,"accession":"0001567619-21-004508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-004508","line_url":"/filing/0001567619-21-004508#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2488.0,"shares_display":"2,488","price_per_share":17.4511,"price_display":"17.45","price_state":"stated","total_value":43418.3368,"total_display":"43,418.34","total_whole":"43,418","shares_owned_after":59739.0,"shares_owned_after_display":"59,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":4323275,"accession":"0001567619-21-001335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-001335","line_url":"/filing/0001567619-21-001335#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":17.9408,"price_display":"17.94","price_state":"stated","total_value":44852.0,"total_display":"44,852.00","total_whole":"44,852","shares_owned_after":59739.0,"shares_owned_after_display":"59,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":2948811,"accession":"0001567619-20-021405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-021405","line_url":"/filing/0001567619-20-021405#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":17.512,"price_display":"17.51","price_state":"stated","total_value":43780.0,"total_display":"43,780.00","total_whole":"43,780","shares_owned_after":32569.0,"shares_owned_after_display":"32,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-21","scope":"insider"},{"id":2715321,"accession":"0001567619-20-020818","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-020818","line_url":"/filing/0001567619-20-020818#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8791.0,"shares_display":"8,791","price_per_share":18.4161,"price_display":"18.42","price_state":"stated","total_value":161895.9351,"total_display":"161,895.94","total_whole":"161,896","shares_owned_after":32569.0,"shares_owned_after_display":"32,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider"},{"id":2582595,"accession":"0001567619-20-020705","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-020705","line_url":"/filing/0001567619-20-020705#line-6","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":18.8509,"price_display":"18.85","price_state":"stated","total_value":923694.1,"total_display":"923,694.10","total_whole":"923,694","shares_owned_after":32569.0,"shares_owned_after_display":"32,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-07","scope":"insider"},{"id":2582586,"accession":"0001567619-20-020705","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-020705","line_url":"/filing/0001567619-20-020705#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49756.0,"shares_display":"49,756","price_per_share":18.6727,"price_display":"18.67","price_state":"stated","total_value":929078.8612,"total_display":"929,078.86","total_whole":"929,079","shares_owned_after":32569.0,"shares_owned_after_display":"32,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider"},{"id":2116161,"accession":"0001567619-20-020096","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-020096","line_url":"/filing/0001567619-20-020096#line-6","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4283.0,"shares_display":"4,283","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":77094.0,"total_display":"77,094.00","total_whole":"77,094","shares_owned_after":32569.0,"shares_owned_after_display":"32,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2116153,"accession":"0001567619-20-020096","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-20-020096","line_url":"/filing/0001567619-20-020096","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18487.0,"shares_display":"18,487","price_per_share":17.6565420565803,"price_display":"17.66","price_state":"stated","total_value":326416.493,"total_display":"326,416.49","total_whole":"326,416","shares_owned_after":36136.0,"shares_owned_after_display":"36,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":3},{"id":3192254,"accession":"0001567619-20-018056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-018056","line_url":"/filing/0001567619-20-018056#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3217.0,"shares_display":"3,217","price_per_share":17.8911,"price_display":"17.89","price_state":"stated","total_value":57555.6687,"total_display":"57,555.67","total_whole":"57,556","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-21","scope":"insider"},{"id":3150966,"accession":"0001567619-20-016945","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-016945","line_url":"/filing/0001567619-20-016945#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.8432,"price_display":"18.84","price_state":"stated","total_value":94216.0,"total_display":"94,216.00","total_whole":"94,216","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-21","scope":"insider"},{"id":2097709,"accession":"0001567619-20-015756","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-015756","line_url":"/filing/0001567619-20-015756#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.3702,"price_display":"19.37","price_state":"stated","total_value":96851.0,"total_display":"96,851.00","total_whole":"96,851","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3106671,"accession":"0001567619-20-013539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-013539","line_url":"/filing/0001567619-20-013539#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.2458,"price_display":"18.25","price_state":"stated","total_value":273687.0,"total_display":"273,687.00","total_whole":"273,687","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-07-21","scope":"insider"},{"id":2531843,"accession":"0001567619-20-012458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-012458","line_url":"/filing/0001567619-20-012458#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":17.22,"price_display":"17.22","price_state":"stated","total_value":43050.0,"total_display":"43,050.00","total_whole":"43,050","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-19","scope":"insider"},{"id":2376252,"accession":"0001567619-20-010834","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-010834","line_url":"/filing/0001567619-20-010834","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3093.0,"shares_display":"3,093","price_per_share":17.17,"price_display":"17.17","price_state":"stated","total_value":53106.81,"total_display":"53,106.81","total_whole":"53,107","shares_owned_after":48556.0,"shares_owned_after_display":"48,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider","n_lines":2},{"id":2921202,"accession":"0001567619-20-008227","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-008227","line_url":"/filing/0001567619-20-008227#line-3","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5150.0,"shares_display":"5,150","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":87550.0,"total_display":"87,550.00","total_whole":"87,550","shares_owned_after":47846.0,"shares_owned_after_display":"47,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-21","scope":"insider"},{"id":2921198,"accession":"0001567619-20-008227","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-008227","line_url":"/filing/0001567619-20-008227#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.57,"price_display":"15.57","price_state":"stated","total_value":77850.0,"total_display":"77,850.00","total_whole":"77,850","shares_owned_after":52996.0,"shares_owned_after_display":"52,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-21","scope":"insider"},{"id":2366913,"accession":"0001567619-20-004436","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-20-004436","line_url":"/filing/0001567619-20-004436","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.639,"price_display":"21.64","price_state":"stated","total_value":216390.0,"total_display":"216,390.00","total_whole":"216,390","shares_owned_after":52996.0,"shares_owned_after_display":"52,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider","n_lines":3},{"id":2761964,"accession":"0001567619-20-001353","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-20-001353","line_url":"/filing/0001567619-20-001353","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.59305,"price_display":"19.59","price_state":"stated","total_value":195930.5,"total_display":"195,930.50","total_whole":"195,931","shares_owned_after":57996.0,"shares_owned_after_display":"57,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-17","filed_date":"2020-01-22","scope":"insider","n_lines":3},{"id":8406547,"accession":"0001567619-19-023319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-023319","line_url":"/filing/0001567619-19-023319#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.69,"price_display":"18.69","price_state":"stated","total_value":46725.0,"total_display":"46,725.00","total_whole":"46,725","shares_owned_after":19326.0,"shares_owned_after_display":"19,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider"},{"id":8610712,"accession":"0001567619-19-021759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-021759","line_url":"/filing/0001567619-19-021759#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":19.26,"price_display":"19.26","price_state":"stated","total_value":48150.0,"total_display":"48,150.00","total_whole":"48,150","shares_owned_after":19310.0,"shares_owned_after_display":"19,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":8634392,"accession":"0000899243-19-025608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-025608","line_url":"/filing/0000899243-19-025608#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.4,"price_display":"18.40","price_state":"stated","total_value":46000.0,"total_display":"46,000.00","total_whole":"46,000","shares_owned_after":19310.0,"shares_owned_after_display":"19,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-14","filed_date":"2019-10-16","scope":"insider"},{"id":8634336,"accession":"0000899243-19-023816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-023816","line_url":"/filing/0000899243-19-023816#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.03,"price_display":"20.03","price_state":"stated","total_value":50075.0,"total_display":"50,075.00","total_whole":"50,075","shares_owned_after":19310.0,"shares_owned_after_display":"19,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-18","scope":"insider"},{"id":8544784,"accession":"0000899243-19-021944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-021944","line_url":"/filing/0000899243-19-021944#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":47500.0,"total_display":"47,500.00","total_whole":"47,500","shares_owned_after":19310.0,"shares_owned_after_display":"19,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":7934939,"accession":"0000899243-19-019764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-019764","line_url":"/filing/0000899243-19-019764#line-2","is_derivative":false,"issuer_cik":"0001512762","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001512762","owner_cik":"0001733375","owner_name":"Anicetti Vincent R","owner_display_name":"Anicetti Vincent R","owner_url":"/insider/0001733375","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":19.2,"price_display":"19.20","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":19310.0,"shares_owned_after_display":"19,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001512762","name":"Coherus BioSciences, Inc.","url":"/issuer/0001512762","role":"Officer (Chief Operating Officer)","n_filings":22,"first_seen":"2019-07-17","last_seen":"2021-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733375","retrieved_at":"2026-08-25T13:35:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}